Signpost Cancer Analytics Inc. Inc. to Present at the Midwest Venture Capital Consortium

By Sari Cross | September 14, 2020

September 14, 2020 – Ontario, Canada – Signpost Cancer Analytics Inc. Inc. (“SignPost” or “company”), a company developing an advanced molecular diagnostic test to identify invasive breast cancer is pleased to be presenting at the Midwest Venture Capital Consortium.  The event will be held virtually on Monday, September 14, 2020, from 3-4pmCT. SignPost will be…

Read More